Navigation Links
Rochester Medical Director Schnobrich to Retire
Date:12/23/2011

STEWARTVILLE, Minn., Dec. 23, 2011 /PRNewswire/ -- Rochester Medical Corporation (Nasdaq: ROCM) announced today that Roger W. Schnobrich will retire from its Board of Directors following the conclusion of the Company's 2012 Annual Meeting of Shareholders to be held on January 26, 2012, which is the end of his current term.

Board Chairman and CEO Anthony J. Conway stated that "Mr. Schnobrich has served on our Board since 1995.  His cheerful intelligence and gracious temperament have served the Company well.  He is a man of excellent character and dignity, and Rochester Medical Corporation has benefited greatly from these traits over the years.

"Our many thanks for working with us, Roger. I know you will continue to enjoy each day."

Conway continued, "I am very pleased to announce that the Board of Directors has nominated Peter H. Shepard for election as a Director for Rochester Medical Corporation at the 2012 Annual Meeting.  Mr. Shepard has deep knowledge and experience in the medical device industry and is particularly expert in the field of Urology and Incontinence.  Mr. Shepard's extensive sales and marketing experience will enable him to provide valuable insight and guidance to our management team with respect to our strategic initiatives to grow sales domestically and internationally."

About Rochester Medical Corporation

Rochester Medical Corporation develops, manufactures, and markets disposable medical catheters and devices for urological and continence care applications.  The Company also sells certain ostomy and wound and scar care products and other brands of urological products into the European marketplace.

For further information, please contact Anthony J. Conway, President and Chief Executive Officer or David A. Jonas, Chief Financial Officer of Rochester Medical Corporation at (507) 533-9600 or Parice Halbert, CFA, at Westwicke Partners (443) 213-0500.  More information about the 2012 Annual Meeting of Shareholders is included in the Company's proxy statement filed with the Securities and Exchange Commission on December 23, 2011.  More information about Rochester Medical is available on its website at http://www.rocm.com.


'/>"/>
SOURCE Rochester Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rochester Medical Reports Fourth Quarter and Fiscal Year End Results
2. Rochester Medical Announces Fourth Quarter 2011 Earnings Conference Call Thursday, November 3, 2011
3. Rochester Medical Implants Relocates to New Facility in Noblesville, IN
4. Rochester Medical Reports Fiscal 2011 Third Quarter Results
5. Rochester Medical Announces Third Quarter 2011 Earnings Conference Call Thursday, July 28, 2011
6. Rochester Medical Reports Second Quarter Results
7. Rochester Medical Announces Second Quarter 2011 Earnings Conference Call Thursday, May 5, 2011
8. Rochester Medical Completes Acquisition of Laprolan
9. Fornix Shareholders Approve the Sale of Laprolan B.V. to Rochester Medical Corporation
10. Rochester Medical Reports First Quarter Results and Recent Developments
11. Rochester Medical Announces First Quarter 2011 Earnings Conference Call Tuesday, January 25, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan. 18, 2017  Aprima Medical ... records (EHR), practice management (PM) and revenue cycle ... the acquisition of a former reseller Healthcare Data ... of the agreement, Aprima will assume full support ... in 125 medical practices across 15 states. Financial ...
(Date:1/18/2017)... 18, 2017 The Philadelphia Pediatric Medical Device Consortium ... devices for children. The Consortium chose those companies ... of $50,000 each. The devices under development are ... a hand-operated rapid blood delivery system for emergency situations and ... ...
(Date:1/18/2017)... , Jan. 18, 2017   Regenicin, Inc. ... biotechnology company specializing in the development and commercialization of ... tissues and organs, recently reported the Company,s operating results ... 2017. As the Company described in its ... a year of substantial accomplishments. The Company,s contract laboratory ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... 19, 2017 , ... Attorney Robert “RC” Pate , founder of The ... the Triumph Over Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric ... firsthand the effect of the critical funding gap for research into pediatric cancer research. ...
(Date:1/19/2017)... ... ... Connecticut Dermatology Group (CDG) is proud and excited to welcome back to the ... brings an extensive background in cutting-edge dermatology care and research to Connecticut’s largest ... Kim to the CDG team” said President and Managing Partner Dr. Steven A. Kolenik ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of surgeons from ... in breast surgery. Covering topics from cosmetic breast augmentation to breast ...
(Date:1/18/2017)... ... ... From a health perspective, 2017 will clearly be the Year of the Gut. ... health and general physical well-being. The New York Times suggested a “ Gut Makeover ... Charlottesville restaurant, good gut health is clearly on the menu. Threepenny Cafe ...
(Date:1/18/2017)... ... January 18, 2017 , ... The V Foundation for ... V, its official endurance training and fundraising team, to compete in the Boston Marathon ... those inspired to finish the world’s oldest annual marathon to join Team V and ...
Breaking Medicine News(10 mins):